FDA Approved: NORTHERA — Supplemental Application (Lundbeck Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved a supplemental application for NORTHERA (droxidopa) submitted by Lundbeck Pharmaceuticals LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurogenic Orthostatic Hypotension

Drugs mentioned

• Northera (droxidopa)

Snippet

SUPPL AP for NORTHERA (DROXIDOPA)